Provexis plc Logo

Provexis plc (PXS)

LSE

Currency in GBp
1.09
-0.03 (-3.11%)

Closed

Aug 25, 2026

Day's Range

1.00
1.25

52 wk Range

0.00618
1.55

Overview - PXS - Provexis plc

Key Statistics

Valuation

Enterprise Value

25.33M

P/E (Trailing)

‪-5,625.00‬

Price / Sales (TTM)

‪27.59‬

EV / EBITDA

‪-56.05‬

Profitability

Profit Margin

‪-69.30%‬

Operating Margin

‪-85.00%‬

Return on Assets

‪-46.13%‬

Return on Equity

‪-125.49%‬

Ownership

Shares Outstanding

2.34B

Float

1.80B

Held by Insiders

‪20.84%‬

Held by Institutions

‪9.86%‬

Price stats

Beta

‪0.66‬

50-Day Avg

‪1.17‬

200-Day Avg

‪1.04‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - PXS - Provexis plc

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.

Profile Summary - PXS - Provexis plc

About

Provexis plc is a public limited company specializing in the development, licensing, and commercialization of innovative functional food ingredients, particularly its proprietary Fruitflow technology. Fruitflow, a natural tomato extract available in syrup and powder forms, helps maintain normal platelet aggregation to…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.